Show simple item record

dc.contributor.authorHARMAN, Sen_US
dc.contributor.editorPhillips, Nen_US
dc.contributor.editorPayne, Aen_US
dc.date.accessioned2015-08-14T14:20:33Z
dc.date.issued2014-04en_US
dc.identifier.isbn0857933477en_US
dc.identifier.isbn9780857933478en_US
dc.identifier.other17
dc.identifier.other17
dc.identifier.other17
dc.identifier.other17en_US
dc.identifier.other17en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/8165
dc.description.abstractInnovation has become a buzz-word in the political economy of governance. Whether used in the context of higher education reforms, investment in domestic manufacturing, beauty products for ageing populations, or solutions to climate change, this buzz-word is meant to reflect the emphasis on new ideas, new structures, new solutions and new forms of financing for contemporary global political issues. The use of innovation has been particularly popular in describing new forms of governance, funding, projects and approaches for tackling global health problems. New public-private partnerships, such as the Global Alliance for Vaccines and Immunisation (GAVI Alliance), describe themselves as innovative; Bill Gates has advocated the need for more innovation to solve global health problems; and philanthropic donors continue to set aside funds for researchers to innovate. Yet in these different contexts the meaning of the word 'innovation' remains slightly dubious: all that is certain is that people working in global health like to use it, and describing something as innovative is generally seen as positive. Conventionally, the word 'innovation' refers to the introduction of new ideas, methods or change, and is applied to describe research outcomes, new findings or something that the world needs more ofen_US
dc.format.extent312 - 329 (17)en_US
dc.language.isoenen_US
dc.publisherEdward Elgar Publishingen_US
dc.relation.ispartofHandbook of the International Political Economy of Governanceen_US
dc.subjecteconomics and financeen_US
dc.subjectpolitical economyen_US
dc.subjectpoliticsen_US
dc.subjectpublic policyen_US
dc.subjectinternational politicsen_US
dc.subjectregulation and governanceen_US
dc.titleInnovation and the limits of rebranded privatisation in Global Healthen_US
dc.typeBook chapter
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.publisher-urlhttp://www.e-elgar.com/bookentry_main.lasso?id=14421&sub_values=en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record